Radiation Business Solutions Launches Anoma Cancer Collective
Radiation Business Solutions (RBS) has made a significant move by forming the Anoma Cancer Collective (ACC), its second 501(c)3 nonprofit oncology foundation. This initiative is designed to extend its mission-driven model by offering invaluable support to cancer centers throughout the country. The closing of this transaction is anticipated by the end of 2025 or early 2026.
Expanding Horizons for Cancer Care
The establishment of ACC builds upon the favorable outcomes achieved with the Aurora Integrated Oncology Foundation. ACC presents a strategic pathway for both physician-owned cancer centers and hospital-affiliated programs that are encountering difficulties related to operational sustainability or financial resources. By converting to a nonprofit status and gaining access to tax-exempt bond funding, these centers can secure the necessary capital for essential equipment upgrades and facility enhancements, ensuring their longevity while maintaining their foundational missions.
The Challenges in the Oncology Landscape
Dan Moore, the CEO of Radiation Business Solutions, highlights the daunting challenges that cancer centers currently face, including escalating costs, uncertainties in reimbursements, and a scarcity of capital. In light of these issues, many centers are contemplating closure. ACC emerges as a robust alternative, providing a crucial lifeline for healthcare providers and hospitals eager to retain independence, enhance technologies, and continue delivering essential services to their communities.
Opportunities for Growing Networks
The foundation's operational focus will span the continental United States, actively inviting radiation oncologists and oncology groups to become part of an expanding network dedicated to mission-driven care.
RBS's Impact on Cancer Care
RBS, with its offices situated in various states, serves over 2,700 cancer patients daily. The company plays a pivotal role by offering strategic consulting, joint venture opportunities, succession planning, comprehensive billing services, prior authorizations, and advancements in predictive services within the proton treatment domain. Through case rate negotiations, the launching of new sites, and investment avenues, RBS continues to be a leader in the oncology sector.
For additional information, the public is encouraged to explore their services.
Frequently Asked Questions
What is the Anoma Cancer Collective?
The Anoma Cancer Collective is a new nonprofit oncology foundation launched by Radiation Business Solutions to support cancer centers in the U.S.
Why was the Anoma Cancer Collective created?
ACC was established to provide financial solutions and operational support to struggling cancer centers, helping them remain independent and sustainable.
How will ACC assist cancer centers?
ACC will offer access to tax-exempt bond funding that will enable cancer centers to upgrade their equipment and facilities while sustaining their missions.
What challenges do cancer centers face today?
Cancer centers are dealing with rising costs, uncertainties in reimbursement, and limited capital, making it hard for some to stay operational.
How many patients does RBS impact daily?
Radiation Business Solutions impacts over 2,700 cancer patients each day through its various strategic services and initiatives.
